Does a stock usually get delisted at a hearing

**A stock does not necessarily get delisted at a hearing.** The outcome of the hearing depends on the company's ability to present a compelling case for reconsideration and the specific circumstances of the delisting violation. Here are some key points to consider: 1. **Company's Case**: The company must demonstrate that it has taken sufficient action to address the delisting issues and provide a credible plan for regaining compliance with the exchange's listing requirements. 2. **Hearing Panel's Decision**: The hearings panel, responsible for reviewing delisting determinations, will carefully examine the company's appeal. They have the authority to either affirm the delisting or overturn the decision based on the merits of the case. 3. **Additional Review**: If necessary, the Nasdaq Listing and Hearings Review Council may also assess the company's appeal, ensuring that the decision-making process is thorough and fair. 4. **Final Discretion**: In extreme cases, the Nasdaq Board of Directors retains the discretion to call for a review of a Listing Council Decision, allowing for a comprehensive evaluation of all aspects related to the delisting notice. In conclusion, while a company like CNS Pharmaceuticals has requested a hearing to challenge Nasdaq's delisting notice, the ultimate outcome is uncertain. The company's ability to present a strong case for reconsideration and the specific circumstances of the delisting violation will be critical factors in determining whether CNSP can overcome the delisting decision.